Most cited papers from Polymun (Austria)

Polymun (Austria)

What are the most cited papers from Polymun (Austria)?

The most cited paper from Polymun (Austria) is "Generation of glyco‐engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human‐like N‐glycan structure" (Richard Strasser, Johannes Stadlmann, Matthias Schähs et al., 2008), with 531 citations. Next come "Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies" (514) and "Liposome Technology for Industrial Purposes" (437).

Published TypeFieldAccessCitations

Showing 50 of 61 papers. Every paper with more than 28 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Generation of glyco‐engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human‐like N‐glycan structure Richard Strasser, Johannes Stadlmann, Matthias Schähs et al. · Plant Biotechnology Journal Open access	13 Mar 2008	531
2	Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies Alexandra Trkola, Herbert Kuster, Peter Rusert et al. · Nature Medicine	8 May 2005	514
3	Liposome Technology for Industrial Purposes Andreas Wagner, Karola Vorauer‐Uhl · Journal of Drug Delivery Open access	5 Dec 2010	437
4	Regulatory approval and a first‐in‐human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants Julian K‐C. et al. · Plant Biotechnology Journal Open access	3 Jul 2015	265
5	In Planta Protein Sialylation through Overexpression of the Respective Mammalian Pathway Alexandra Castilho, Richard Strasser, Johannes Stadlmann et al. · Journal of Biological Chemistry Open access	20 Mar 2010	231
6	Process parameter shifting: Part I. Effect of DOT, pH, and temperature on the performance of Epo‐Fc expressing CHO cells cultivated in controlled batch bioreactors Evelyn Trummer, Katharina Fauland, Silke Seidinger et al. · Biotechnology and Bioengineering	30 May 2006	220
7	Improved Virus Neutralization by Plant-produced Anti-HIV Antibodies with a Homogeneous β1,4-Galactosylated N-Glycan Profile Richard Strasser, Alexandra Castilho, Johannes Stadlmann et al. · Journal of Biological Chemistry Open access	29 May 2009	179
8	Recombinant antibody 2G12 produced in maize endosperm efficiently neutralizes HIV‐1 and contains predominantly single‐GlcNAc N ‐glycans Thomas W. Rademacher, M. Sack, Elsa Arcalís et al. · Plant Biotechnology Journal Open access	4 Nov 2007	174
9	Protective effect of vaginal application of neutralizing and nonneutralizing inhibitory antibodies against vaginal SHIV challenge in macaques Christiane Moog, N Dereuddre-Bosquet, J-L Teillaud et al. · Mucosal Immunology Open access	17 Apr 2013	159
10	Cost-effective production of a vaginal protein microbicide to prevent HIV transmission Koreen Ramessar, Thomas W. Rademacher, M. Sack et al. · Proceedings of the National Academy of Sciences Open access	3 Mar 2008	158
11	Complete Protection of Neonatal Rhesus Macaques against Oral Exposure to Pathogenic Simian‐Human Immunodeficiency Virus by Human Anti‐HIV Monoclonal Antibodies Flavia Ferrantelli, Robert A. Rasmussen, Kathleen A. Buckley et al. · The Journal of Infectious Diseases	2 Jun 2004	158
12	A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc™) in patients with locally advanced or metastatic cancer Richard Greil, Sigrun Greil‐Ressler, Lukas Weiß et al. · Cancer Chemotherapy and Pharmacology Open access	3 Aug 2018	139
13	A phase I trial with two human monoclonal antibodies (hMAb 2F5, 2G12) against HIV-1 Christine Armbruster, Gabriela M. Stiegler, Brigitta A. Vcelar et al. · AIDS	2002	130
14	Adjunctive Passive Immunotherapy in Human Immunodeficiency Virus Type 1-Infected Individuals Treated with Antiviral Therapy during Acute and Early Infection Saurabh Mehandru, Brigitta A. Vcelar, Terri Wrin et al. · Journal of Virology Open access	9 Aug 2007	123
15	THE CROSSFLOW INJECTION TECHNIQUE: AN IMPROVEMENT OF THE ETHANOL INJECTION METHOD Andreas Wagner, Karola Vorauer‐Uhl, Günther Kreismayr et al. · Journal of Liposome Research	2002	122
16	Anti-neuroblastoma effect of ch14.18 antibody produced in CHO cells is mediated by NK-cells in mice Yan Zeng, Stefan Fest, Renate Kunert et al. · Molecular Immunology	8 Apr 2005	113
17	Post-exposure prophylaxis with human monoclonal antibodies prevented SHIV89.6P infection or disease in neonatal macaques Flavia Ferrantelli, Regina Hofmann‐Lehmann, Robert A. Rasmussen et al. · AIDS	Feb 2003	107
18	Liposomes produced in a pilot scale: production, purification and efficiency aspects Andreas Wagner, Karola Vorauer‐Uhl, Hermann W. D. Katinger · European Journal of Pharmaceutics and Biopharmaceutics	Sep 2002	101
19	In Vivo and In Vitro Escape from Neutralizing Antibodies 2G12, 2F5, and 4E10 Amapola Manrique, Peter Rusert, Béda Joos et al. · Journal of Virology Open access	14 Jun 2007	95
20	Bioprocessing of Recombinant CHO-K1, CHO-DG44, and CHO-S: CHO Expression Hosts Favor Either mAb Production or Biomass Synthesis David Reinhart, Lukas Damjanovic, Christian Kaisermayer et al. · Biotechnology Journal Open access	27 Apr 2018	93
21	Functional analysis of the broadly neutralizing human anti‐HIV‐1 antibody 2F5 produced in transgenic BY‐2 suspension cultures M. Sack, Antje Paetz, Renate Kunert et al. · The FASEB Journal	27 Feb 2007	90
22	Inhibition of In Vivo HIV Infection in Humanized Mice by Gene Therapy of Human Hematopoietic Stem Cells with a Lentiviral Vector Encoding a Broadly Neutralizing Anti-HIV Antibody Aviva Joseph, Jian Hua Zheng, Ken Chen et al. · Journal of Virology Open access	21 Apr 2010	84
23	Generation of Biologically Active Multi-Sialylated Recombinant Human EPOFc in Plants Alexandra Castilho, Laura Neumann, Pia Gattinger et al. · PLoS ONE Open access	25 Jan 2013	82
24	Ch14.18 antibody produced in CHO cells in relapsed or refractory Stage 4 neuroblastoma patients Ruth Lydia Ladenstein, Silke Weixler, Bianca Baykan et al. · mAbs Open access	31 May 2013	81
25	Virus Isolates during Acute and Chronic Human Immunodeficiency Virus Type 1 Infection Show Distinct Patterns of Sensitivity to Entry Inhibitors Peter Rusert, Herbert Kuster, Béda Joos et al. · Journal of Virology Open access	15 Jun 2005	80
26	Neutralization Profiles of Newly Transmitted Human Immunodeficiency Virus Type 1 by Monoclonal Antibodies 2G12, 2F5, and 4E10 Saurabh Mehandru, Terri Wrin, Justin Galovich et al. · Journal of Virology Open access	24 Nov 2004	78
27	Process parameter shifting: Part II. Biphasic cultivation—A tool for enhancing the volumetric productivity of batch processes using Epo‐Fc expressing CHO cells Evelyn Trummer, Katharina Fauland, Silke Seidinger et al. · Biotechnology and Bioengineering	30 May 2006	76
28	Antibodies to conserved epitopes of the HIV-1 envelope in sera from long-term non-progressors: prevalence and association with neutralizing activity Martine Braibant, S. Brunet, Dominique G. Costagliola et al. · AIDS	21 Sep 2006	76
29	Liposomal Recombinant Human Superoxide Dismutase for the Treatment of Peyronie's Disease: A Randomized Placebo-Controlled Double-Blind Prospective Clinical Study CLAUS R. RIEDL, Peter Sternig, Günter Gallè et al. · European Urology	12 May 2005	66
30	Glycan profiles of the 27 N-glycosylation sites of the HIV envelope protein CN54gp140 Martin Pabst, Martina Wei-Fen Chang, Johannes Stadlmann et al. · Biological Chemistry	Aug 2012	63
31	Long-Term Multiple-Dose Pharmacokinetics of Human Monoclonal Antibodies (MAbs) against Human Immunodeficiency Virus Type 1 Envelope gp120 (MAb 2G12) and gp41 (MAbs 4E10 and 2F5) Béda Joos, Alexandra Trkola, Herbert Kuster et al. · Antimicrobial Agents and Chemotherapy	26 Apr 2006	62
32	Biochemical characterization of rhEpo-Fc fusion protein expressed in CHO cells Kornelia Schriebl, Evelyn Trummer, Christine Lattenmayer et al. · Protein Expression and Purification	16 Jun 2006	60
33	In Vivo Efficacy of Human Immunodeficiency Virus Neutralizing Antibodies: Estimates for Protective Titers Alexandra Trkola, Herbert Kuster, Peter Rusert et al. · Journal of Virology Open access	22 Nov 2007	56
34	Characterisation of recombinant CHO cell lines by investigation of protein productivities and genetic parameters Christine Lattenmayer, Evelyn Trummer, Kornelia Schriebl et al. · Journal of Biotechnology	31 Dec 2006	54
35	Sustained release of proteins from a modified vaginal ring device Ryan J. Morrow, A. David Woolfson, Louise Donnelly et al. · European Journal of Pharmaceutics and Biopharmaceutics Open access	4 Nov 2010	53
36	HIV-1 mutants escaping neutralization by the human antibodies 2F5, 2G12, and 4E10: in vitro experiments versus clinical studies Sabine Nakowitsch, Heribert Quendler, Helga Fekete et al. · AIDS	31 Oct 2005	52
37	Expression of functionally active sialylated human erythropoietin in plants Jakub Jeż, Alexandra Castilho, Josephine Grass et al. · Biotechnology Journal Open access	17 Jan 2013	50
38	Heterologous protein production using euchromatin-containing expression vectors in mammalian cells Katalin Zboray, Wolfgang Sommeregger, Edith Bogner et al. · Nucleic Acids Research Open access	14 May 2015	50
39	Reassessment of autoreactivity of the broadly neutralizing HIV antibodies 4E10 and 2F5 and retrospective analysis of clinical safety data Brigitta A. Vcelar, Gabriela M. Stiegler, Hermann Maximilian Wolf et al. · AIDS	Oct 2007	48
40	Potent Cross‐Group Neutralization of Primary Human Immunodeficiency Virus Isolates with Monoclonal Antibodies—Implications for Acquired Immunodeficiency Syndrome Vaccine Flavia Ferrantelli, Moiz Kitabwalla, Robert A. Rasmussen et al. · The Journal of Infectious Diseases	2004	46
41	Live attenuated influenza viruses produced in a suspension process with avian AGE1.CR.pIX cells Verena Lohr, Yvonne Genzel, Ingo Jordan et al. · BMC Biotechnology Open access	30 Oct 2012	43
42	Reepithelialization of experimental scalds effected by topically applied superoxide dismutase: controlled animal studies Karola Vorauer‐Uhl, Eckhard Fürnschlief, Andreas Wagner et al. · Wound Repair and Regeneration	Nov 2002	43
43	ENHANCED PROTEIN LOADING INTO LIPOSOMES BY THE MULTIPLE CROSSFLOW INJECTION TECHNIQUE Andreas Wagner, Karola Vorauer‐Uhl, Günther Kreismayr et al. · Journal of Liposome Research	2002	42
44	Analysis of recombinant human follicle-stimulating hormone (FSH) by mass spectrometric approaches Josephine Grass, Martin Pabst, Martina Wei-Fen Chang et al. · Analytical and Bioanalytical Chemistry	2 Apr 2011	42
45	Proteomic differences in recombinant CHO cells producing two similar antibody fragments Wolfgang Sommeregger, Patrick Mayrhofer, Willibald Steinfellner et al. · Biotechnology and Bioengineering Open access	25 Feb 2016	40
46	High level expression of a promising anti-idiotypic antibody fragment vaccine against HIV-1 in Pichia pastoris Johannes S. Gach, Michael Maurer, Rainer Hahn et al. · Journal of Biotechnology	11 Jan 2007	40
47	Repeated vaginal administration of trimeric HIV-1 clade C gp140 induces serum and mucosal antibody responses Martin P Cranage, Caroline Fraser, Zoe Stevens et al. · Mucosal Immunology Open access	9 Sep 2009	39
48	Escape the Fake: Development and Evaluation of an Augmented Reality Escape Room Game for Fighting Fake News Irina Paraschivoiu, Josef Buchner, Robert Praxmarer et al. Conference paper	15 Oct 2021	37
49	Time dependence of protective post-exposure prophylaxis with human monoclonal antibodies against pathogenic SHIV challenge in newborn macaques Flavia Ferrantelli, Kathleen A. Buckley, Robert A. Rasmussen et al. · Virology Open access	26 Sep 2006	37
50	Comparison of carbamylated erythropoietin-FC fusion protein and recombinant human erythropoietin during porcine aortic balloon occlusion-induced spinal cord ischemia/reperfusion injury Florian Simon, Angelika Scheuerle, Michael Gröger et al. · Intensive Care Medicine Open access	15 Jul 2011	36

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.